Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Transfusion-dependent Anemia”

159 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 159 results

Post-approval studies (Phase 4)Not Yet RecruitingNCT06525948
What this trial is testing

Efficacy and Safety of rhTPO in Combination With Cyclosporine Versus Cyclosporine Alone in the Treatment of TD-NSAA

Who this might be right for
Aplastic AnemiaTransfusion-dependent Anemia
Peking Union Medical College Hospital 54
Post-approval studies (Phase 4)WithdrawnNCT02069886
What this trial is testing

Effect of Deferasirox on Endocrine Complications in Subjects With Transfusion Dependent Thalassemia

Who this might be right for
Thalassemia (Transfusion Delendent)
Novartis Pharmaceuticals
Large-scale testing (Phase 3)Not Yet RecruitingNCT07548671
What this trial is testing

Enarodustat + CsA vs CsA in Newly Diagnosed TD-NSAA

Who this might be right for
Transfusion-dependent Non-severe Aplastic Anemia
Peking Union Medical College Hospital 90
Testing effectiveness (Phase 2)Looking for participantsNCT07096297
What this trial is testing

Luspatercept + Darbepoetin in MDS

Who this might be right for
MDS (Myelodysplastic Syndrome)
Yale University 60
Post-approval studies (Phase 4)Study completedNCT03032666
What this trial is testing

Sofosbuvir/Ledipasvir for Hepatitis C Genotype 1-6 in Patients With Transfusion-Dependent Thalassemia: An Open Label Trial

Who this might be right for
ThalassemiaHepatitis C
Ala'a Sharara 7
Early research (Phase 1)Ended earlyNCT04925206
What this trial is testing

A Safety and Efficacy Study Evaluating ET-01 in Subjects with Transfusion Dependent Β-Thalassaemia

Who this might be right for
Transfusion Dependent Beta-Thalassaemia
EdiGene (GuangZhou) Inc. 8
Not applicableStudy completedNCT05466370
What this trial is testing

Prediction of Transfusion-Associated Complications

Who this might be right for
Transfusion-dependent Anemia
Kepler University Hospital 3,366
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07558434
What this trial is testing

CsA+EPAG/HPAG+Romiplostim N01 in Newly-diagnosed SAA/TD-NSAA

Who this might be right for
Severe Aplastic Anemia (SAA)Transfusion-dependent Non-severe Aplastic Anemia
Peking Union Medical College Hospital 43
Testing effectiveness (Phase 2)Study completedNCT05355766
What this trial is testing

Long-term Clinical Study of CN128 in Thalassemia With Sever Liver Iron Overloaded Patients

Who this might be right for
ThalassemiaIron Overload
Hangzhou Zede Pharma-Tech Co., Ltd. 16
Testing effectiveness (Phase 2)Looking for participantsNCT03653338
What this trial is testing

T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias

Who this might be right for
Sickle Cell AnemiaBeta-thalassemia MajorDiamond-blackfan Anemia
Paul Szabolcs 5
Large-scale testing (Phase 3)Active Not RecruitingNCT03223961
What this trial is testing

A Trial Testing Early vs Late Onset of EPO Alfa Treatment in Lower Risk MDS

Who this might be right for
Myelodysplastic Syndromes
Groupe Francophone des Myelodysplasies 124
Not applicableUnknownNCT03275051
What this trial is testing

Long-term Follow-up of Subjects Treated With OTL-300 for Transfusion Dependent Beta-thalassemia Study (TIGET-BTHAL)

Who this might be right for
Beta Thalassaemia
IRCCS San Raffaele 9
Not applicableActive Not RecruitingNCT05145062
What this trial is testing

Long - Term Follow Up of Sickle Cell Disease and Beta-thalassemia Subjects Previously Exposed to BIVV003 or ST-400.

Who this might be right for
Blood and Lymphatic Diseases
Sangamo Therapeutics 8
Early research (Phase 1)Ended earlyNCT02274233
What this trial is testing

Safety and Pharmacokinetic Study of Escalating Doses of SP-420, an Iron Chelator, in Patients With β-Thalassemia

Who this might be right for
Iron OverloadBeta-Thalassemia
Sideris Pharmaceuticals 24
Testing effectiveness (Phase 2)Study completedNCT02435212
What this trial is testing

Study to Evaluate Treatment Compliance, Efficacy and Safety of an Improved Deferasirox Formulation (Granules) in Pediatric Patients (2-<18 Years Old) With Iron Overload

Who this might be right for
Transfusion-dependent Anemia
Novartis Pharmaceuticals 224
Not applicableStudy completedNCT04155021
What this trial is testing

Knowledge and Attitude in Perioperative Erythrocyte Transfusion in Medical Personnel in Siriraj Hospital

Who this might be right for
Transfusion-dependent Anemia
Siriraj Hospital 250
Large-scale testing (Phase 3)Study completedNCT02906202
What this trial is testing

A Study Evaluating the Efficacy and Safety of the LentiGlobin® BB305 Drug Product in Participants With Transfusion-Dependent β-Thalassemia, Who do Not Have a β0/β0 Genotype

Who this might be right for
Beta-Thalassemia
Genetix Biotherapeutics Inc. 24
Testing effectiveness (Phase 2)Study completedNCT05399732
What this trial is testing

Efficacy and Safety in Transfusion Independent Non-severe Aplastic Anemia

Who this might be right for
Aplastic Anemia
Bing Han 58
Large-scale testing (Phase 3)Study completedNCT07210450
What this trial is testing

Effect of L-Glutamine on Pulmonary Artery Pressure in Patients With Non-Transfusion-Dependent Thalassemia

Who this might be right for
Pulmonary Artery PressureThalassemiaNon-transfusion Dependent Thalassemia
Mazandaran University of Medical Sciences 8
Large-scale testing (Phase 3)Study completedNCT01566695
What this trial is testing

The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPSS) Low Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Myelodysplastic Syndrome
Celgene 216
Load More Results